# A Proton Magnetic Resonance Spectroscopy (1H MRS) Pilot Study Revealing Altered Glutamatergic and Gamma-Aminobutyric Acid (GABA)ergic Neurotransmission in Social Anxiety Disorder (SAD)

**Authors:** Sonja Elsaid, Ruoyu Wang, Stefan Kloiber, Kimberly L. Desmond, Bernard Le Foll

PMC · DOI: 10.3390/ijms26146915 · 2025-07-18

## TL;DR

This study uses brain scans to find differences in brain chemicals related to anxiety in people with social anxiety disorder.

## Contribution

The study identifies altered GABA and glutamate levels in specific brain regions in social anxiety disorder using 1H MRS.

## Key findings

- Increased GABA+ levels in the dorsolateral prefrontal cortex in social anxiety disorder participants.
- Higher Glx levels in the insula of individuals with social anxiety disorder compared to controls.

## Abstract

Social anxiety disorder (SAD) is characterized by fear and avoidance of social situations. Considering the reduced availability of conventional therapies, we aimed to improve our understanding of the biological mechanisms in SAD by evaluating gamma-aminobutyric acid (GABA) and other neurometabolites (including glutamate + glutamine/glutamix (Glx), N-acetyl aspartate (NAA), myo-inositol (mI), total choline (tCho), and total creatine (tCr) in the dorsomedial prefrontal cortex/anterior cingulate cortex (dmPFC/ACC), dorsolateral prefrontal cortex (dlPFC), and the insula). In this pilot study, we recruited 26 (age: 25.3 ± 5.0 years; 61.5% female) individuals with SAD and 26 (age: 25.1 ± 4.4 years; 61.5% female) sex-age-matched controls. Using proton magnetic resonance spectroscopy, we found that compared to the controls, GABA+ macromolecular signal (GABA+) in dlPFC (t = 2.63; p = 0.012) and Glx in the insula (Mann–Whitney U = 178.3; p = 0.024) were higher in the participants with SAD. However, no between-group differences were observed in dmPFC/ACC (t = 0.39; p = 0.699). Increased GABA+ in dlPFC could be explained by aberrant GABA transporters. In the insula, increased Glx may be associated with the dysfunction of glutamate transporters or decreased activity of glutamic acid decarboxylase in the GABAergic inhibitory neurons. However, these proposed mechanisms need to be further investigated in SAD.

## Linked entities

- **Chemicals:** gamma-aminobutyric acid (PubChem CID 119), glutamate (PubChem CID 611), glutamine (PubChem CID 738), N-acetyl aspartate (PubChem CID 65065), myo-inositol (PubChem CID 892)
- **Diseases:** Social anxiety disorder (MONDO:0001247)

## Full-text entities

- **Diseases:** SAD (MESH:D000072861)
- **Chemicals:** mI (MESH:D007294), 1H (-), glutamine (MESH:D005973), creatine (MESH:D003401), choline (MESH:D002794), glutamate (MESH:D018698), GABA (MESH:D005680), N-acetyl aspartate (MESH:C000179)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12295675/full.md

---
Source: https://tomesphere.com/paper/PMC12295675